In the past week, NAOV stock has gone down by -43.97%, with a monthly decline of -54.90% and a quarterly plunge of -71.35%. The volatility ratio for the week is 24.98%, and the volatility levels for the last 30 days are 16.61% for NanoVibronix Inc. The simple moving average for the past 20 days is -41.10% for NAOV’s stock, with a -66.77% simple moving average for the past 200 days.
Is It Worth Investing in NanoVibronix Inc (NASDAQ: NAOV) Right Now?
The 36-month beta value for NAOV is also noteworthy at 1.94. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for NAOV is 0.78M, and at present, short sellers hold a 0.28% of that float. The average trading volume of NAOV on March 17, 2025 was 332.89K shares.
NAOV) stock’s latest price update
NanoVibronix Inc (NASDAQ: NAOV)’s stock price has gone decline by -16.41 in comparison to its previous close of 2.64, however, the company has experienced a -43.97% decrease in its stock price over the last five trading days. businesswire.com reported 2025-03-14 that ELMSFORD, N.Y.–(BUSINESS WIRE)–NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced that an independent health service study of its UroShield® is published in The Australian and New Zealand Continence Journal. The study highlights UroShield’s effectiveness in preventing catheter-associated urinary tract infections (CAUTIs) and recommends its adoption for appropriate patients with indwelling urinary ca.
NAOV Trading at -53.98% from the 50-Day Moving Average
After a stumble in the market that brought NAOV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.21% of loss for the given period.
Volatility was left at 16.61%, however, over the last 30 days, the volatility rate increased by 24.98%, as shares sank -56.97% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -66.55% lower at present.
During the last 5 trading sessions, NAOV fell by -43.97%, which changed the moving average for the period of 200-days by -74.16% in comparison to the 20-day moving average, which settled at $3.75. In addition, NanoVibronix Inc saw -66.01% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NAOV
Current profitability levels for the company are sitting at:
- -0.89 for the present operating margin
- 0.6 for the gross margin
The net margin for NanoVibronix Inc stands at -0.94. The total capital return value is set at -1.35. Equity return is now at value -94.10, with -51.30 for asset returns.
Based on NanoVibronix Inc (NAOV), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -19.52. The debt to equity ratio resting at 0.07. The interest coverage ratio of the stock is -36.89.
Currently, EBITDA for the company is -3.44 million with net debt to EBITDA at 0.4. When we switch over and look at the enterprise to sales, we see a ratio of 0.17. The receivables turnover for the company is 5.67for trailing twelve months and the total asset turnover is 0.7. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.70.
Conclusion
In summary, NanoVibronix Inc (NAOV) has had a bad performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
